Abstract
These days, the use of single nucleotide polymorphisms (SNP) is
increasing for the genetic dissection of complex
common diseases, and many studies have been conducted
to identify SNPs associated with diseases.
If the number of subjects with the objective disease is large enough,
then we detect disease-associated SNPs with statistical tests
by a two-stage replication study design.
For the design, several ways to calculate a power of a test
have been considered. They show that the
well-constructed two-stage replication study designs maintain
enough powers of the tests.
However, we cannot handle a large quantity of data well
for all diseases,
and we perform statistical tests by a one-stage design
for diseases with small sample sizes.
In this paper, we propose a method to estimate the proportion
of significant results of the tests for such diseases
by using a similar method
to calculate the power of statistical tests with the two-stage
replication study design.